In cell therapy, cells are introduced into the human body to either replace endogenous dead/non-functioning cells or to modulate dysfunctional cellular mechanisms. While cell therapy has been closely linked historically to regenerative medicine, the therapeutic potential of nonprogenitor cell therapy has been extensively investigated more recently, particularly the anti-cancer potential of immune cell transfer.
Cell therapy research has made great strides, meaning that the potential of cell therapy has never been greater. Now, as cell therapy moves more and more away from the bench and towards the clinic, the growing necessity of mass production adds a new wrinkle to an old field.
Download this eBook from The Scientist to learn about:
- Some of the common obstacles to cell therapy success
- Scaling up cell production
- The advantages of automation for cell therapy research
- Compliance and regulatory issues for cell therapy workflows
This free eBook was made possible by an educational grant from Beckman Coulter Life Sciences.
